Acceder

Bibliografías temáticas / Antibacterial agents / Artículos de revistas

Artículos de revistas sobre el tema "Antibacterial agents"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Antibacterial agents.

Autor: Grafiati

Publicado: 4 de junio de 2021

Última modificación: 29 de julio de 2024

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Antibacterial agents".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Bremner, John B. "Some approaches to new antibacterial agents". Pure and Applied Chemistry 79, n.º 12 (1 de enero de 2007): 2143–53. http://dx.doi.org/10.1351/pac200779122143.

Texto completo

Resumen

Bacteria use a number of resistance mechanisms to counter the antibacterial challenge, and one of these is the expression of transmembrane protein-based efflux pumps which can pump out antibacterials from within the cells, thus lowering the antibacterial concentration to nonlethal levels. For example, in S. aureus, the NorA pump can pump out the antibacterial alkaloid berberine and ciprofloxacin. One general strategy to reduce the health threat of resistant bacteria is to block a major bacterial resistance mechanism at the same time as interfering with another bacterial pathway or target site. New developments of this approach in the context of dual-action prodrugs and dual-action (or hybrid) drugs in which one action is targeted at blocking the NorA efflux pump and the second action at an alternative bacterial target site (or sites) for the antibacterial action are discussed. The compounds are based on a combination of 2-aryl-5-nitro-1H-indole derivatives (as the NorA efflux pump blocking component) and derivatives of berberine. General design principles, syntheses, antibacterial testing, and preliminary work on modes of action studies are discussed.

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

Verma, Tarawanti y Nitin Bansal. "Triazinone Derivatives as Antibacterial and Antimalarial Agents". Asian Pacific Journal of Health Sciences 6, n.º 2 (junio de 2019): 1–20. http://dx.doi.org/10.21276/apjhs.2019.6.2.1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

Kaye, Elaine T. y Kenneth M. Kaye. "TOPICAL ANTIBACTERIAL AGENTS". Infectious Disease Clinics of North America 9, n.º 3 (septiembre de 1995): 547–59. http://dx.doi.org/10.1016/s0891-5520(20)30685-1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

Thorsteinsson, T., T. Loftsson y M. Masson. "Soft Antibacterial Agents". Current Medicinal Chemistry 10, n.º 13 (1 de julio de 2003): 1129–36. http://dx.doi.org/10.2174/0929867033457520.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

Brickner, Steven J. "Oxazolidinone Antibacterial Agents". Current Pharmaceutical Design 2, n.º 2 (abril de 1996): 175–94. http://dx.doi.org/10.2174/1381612802666220921173820.

Texto completo

Resumen

The oxazolidinones are a new class of synthetic antibacterial agents. These compounds demonstrate potent in vitro and in vivo activity against important human pathogens, including multiple antibiotic-resistant strains of gram positive organisms including the staphylococci, streptococci, and enterococci. The oxazolidinones have a novel mechanism of action, inhibiting bacterial protein synthesis at a very early step prior to initiation. Literature disclosures have described the inability to detect in vitro bacterial resistance development to the oxazolidinones. Only the (S)-enantiomer is active; a new synthetic route yielding oxazolidinones with high optical purity has been reported. This paper will review the spectrum of activity, mechanism of action studies, toxicity issues, and structure activity relationships of the oxazolidinones.

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

Telford, Mark. "Releasing antibacterial agents". Materials Today 7, n.º 12 (diciembre de 2004): 10. http://dx.doi.org/10.1016/s1369-7021(04)00613-3.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Hussar, Daniel A. "New Antibacterial Agents". American Pharmacy 33, n.º 1 (enero de 1993): 41–46. http://dx.doi.org/10.1016/s0160-3450(15)30889-8.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

Kaye, Elaine T. "TOPICAL ANTIBACTERIAL AGENTS". Infectious Disease Clinics of North America 14, n.º 2 (junio de 2000): 321–39. http://dx.doi.org/10.1016/s0891-5520(05)70250-6.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

Lio, Peter A. y Elaine T. Kaye. "Topical Antibacterial Agents". Medical Clinics of North America 95, n.º 4 (julio de 2011): 703–21. http://dx.doi.org/10.1016/j.mcna.2011.03.008.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

Lio, Peter A. y Elaine T. Kaye. "Topical antibacterial agents". Infectious Disease Clinics of North America 18, n.º 3 (septiembre de 2004): 717–33. http://dx.doi.org/10.1016/j.idc.2004.04.008.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Lio, Peter A. y Elaine T. Kaye. "Topical Antibacterial Agents". Infectious Disease Clinics of North America 23, n.º 4 (diciembre de 2009): 945–63. http://dx.doi.org/10.1016/j.idc.2009.06.006.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Korzeniowski, Oksana M. "ANTIBACTERIAL AGENTS IN PREGNANCY". Infectious Disease Clinics of North America 9, n.º 3 (septiembre de 1995): 639–51. http://dx.doi.org/10.1016/s0891-5520(20)30690-5.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

LiPuma, John J. y Terrence L. Stull. "ANTIBACTERIAL AGENTS IN PEDIATRICS". Infectious Disease Clinics of North America 9, n.º 3 (septiembre de 1995): 561–74. http://dx.doi.org/10.1016/s0891-5520(20)30686-3.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

Labro, Marie Thérèse. "Immunomodulation by Antibacterial Agents". Drugs 45, n.º 3 (marzo de 1993): 319–28. http://dx.doi.org/10.2165/00003495-199345030-00001.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

&NA;, &NA;. "Antibacterial agents: viral/ parasitic". Current Opinion in Infectious Diseases 9, n.º 6 (diciembre de 1996): B235—B251. http://dx.doi.org/10.1097/00001432-199612000-00020.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Crunkhorn, Sarah. "Predicting novel antibacterial agents". Nature Reviews Drug Discovery 19, n.º 4 (9 de marzo de 2020): 238. http://dx.doi.org/10.1038/d41573-020-00033-z.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

Melander, Roberta J., Daniel V. Zurawski y Christian Melander. "Narrow-spectrum antibacterial agents". MedChemComm 9, n.º 1 (2018): 12–21. http://dx.doi.org/10.1039/c7md00528h.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

TOTSUKA, KYOICHI. "Pharmacokinetics of antibacterial agents." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 25, n.º 1 (1994): 385–87. http://dx.doi.org/10.3999/jscpt.25.385.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Shavely, S. R. y G. R. Hodges. "NEUROTOXICITY OF ANTIBACTERIAL AGENTS". Pediatric Infectious Disease Journal 4, n.º 2 (marzo de 1985): 219. http://dx.doi.org/10.1097/00006454-198503000-00047.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

San Joaquin, Venusto H. y Terrence L. Stull. "ANTIBACTERIAL AGENTS IN PEDIATRICS". Infectious Disease Clinics of North America 14, n.º 2 (junio de 2000): 341–55. http://dx.doi.org/10.1016/s0891-5520(05)70251-8.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

Ford, Charles W., Judith C. Hamel, Douglas Stapert, Judy K. Moerman, Douglas K. Hutchinson, Michael R. Barbachyn y Gary E. Zurenko. "Oxazolidinones: New antibacterial agents". Trends in Microbiology 5, n.º 5 (mayo de 1997): 196–200. http://dx.doi.org/10.1016/s0966-842x(97)01032-9.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

Jungheim, L. N., R. J. Ternansky y R. E. Holmes. "Bicyclic pyrazolidinone antibacterial agents". Drugs of the Future 15, n.º 2 (1990): 149. http://dx.doi.org/10.1358/dof.1990.015.02.114554.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Bowlware, Karen L. y Terrence Stull. "Antibacterial agents in pediatrics". Infectious Disease Clinics of North America 18, n.º 3 (septiembre de 2004): 513–31. http://dx.doi.org/10.1016/j.idc.2004.04.009.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

Chavez-Bueno, Susana y Terrence L. Stull. "Antibacterial Agents in Pediatrics". Infectious Disease Clinics of North America 23, n.º 4 (diciembre de 2009): 865–80. http://dx.doi.org/10.1016/j.idc.2009.06.011.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

Quesnelle, Claude A., Patrice Gill, Stephan Roy, Marco Dodier, Anne Marinier, Alain Martel, Lawrence B. Snyder et al. "Biaryl isoxazolinone antibacterial agents". Bioorganic & Medicinal Chemistry Letters 15, n.º 11 (junio de 2005): 2728–33. http://dx.doi.org/10.1016/j.bmcl.2005.04.003.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

Meneghetti, Fiorella y Daniela Barlocco. "Novel Antibacterial Agents 2022". Pharmaceuticals 17, n.º 3 (13 de marzo de 2024): 370. http://dx.doi.org/10.3390/ph17030370.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

Gupta, Richa K., Ganesh M. S. Thakuri, Gan B. Bajracharya y Ram Narayan Jha. "Synthesis of antioxidative anthraquinones as potential anticancer agents". BIBECHANA 18, n.º 2 (9 de junio de 2021): 143–53. http://dx.doi.org/10.3126/bibechana.v18i2.31234.

Texto completo

Resumen

Antioxidant and antibacterial activities of natural anthraquinones namely chrysophanol (1) and emodin (2), and synthesized anthraquinones viz. 2-methylanthraquinone (3), anthraquinone (4), 2-bromoanthraquinone (5), rubiadin (6), chrysophanol diacetate (7), rubiadin diacetate (8) and 1,8-dimethoxy-3-methylanthraquinone (9) were investigated. Anthraquinones 9, 3, 6, 5 and 2 exhibited a high DPPH• radical scavenging capacity (IC50 = <500 μg/mL) showing their therapeutic potentiality for the treatment of cancers. These anthraquinones 1-9 have also displayed a weak to moderate antibacterial activity against Bacillus subtilis. Chrysophanol diacetate (7) including emodin (2) have been appeared as the valuable antibacterials. BIBECHANA 18 (2) (2021) 143-153

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

Tavakolian, Mandana, Mira Okshevsky, Theo G. M. van de Ven y Nathalie Tufenkji. "Developing Antibacterial Nanocrystalline Cellulose Using Natural Antibacterial Agents". ACS Applied Materials & Interfaces 10, n.º 40 (12 de septiembre de 2018): 33827–38. http://dx.doi.org/10.1021/acsami.8b08770.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

Kumaraswamy, D. y D. Prashanth. "SYNTHESIS AND EVALUATION OF PYRAZOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS". International Journal of Pharmacy and Biological Sciences 7, n.º 1 (1 de enero de 2017): 84–93. http://dx.doi.org/10.21276/ijpbs.2017.7.1.10.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

Belete, Tafere Mulaw. "Novel targets to develop new antibacterial agents and novel alternatives to antibacterial agents". Human Microbiome Journal 11 (marzo de 2019): 100052. http://dx.doi.org/10.1016/j.humic.2019.01.001.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

31

Hupp, James R. "Antibacterial, Antiviral, and Antifungal Agents". Oral and Maxillofacial Surgery Clinics of North America 3, n.º 2 (mayo de 1991): 273–85. http://dx.doi.org/10.1016/s1042-3699(20)30498-2.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

32

Livornese, Lawrence L., Mark J. Ingerman, Robert L. Benz y Jerome Santoro. "ANTIBACTERIAL AGENTS IN RENAL FAILURE". Infectious Disease Clinics of North America 9, n.º 3 (septiembre de 1995): 591–614. http://dx.doi.org/10.1016/s0891-5520(20)30688-7.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

33

Rubino, Christopher M. y John S. Bradley. "Optimizing Therapy with Antibacterial Agents". Pediatric Drugs 9, n.º 6 (2007): 361–69. http://dx.doi.org/10.2165/00148581-200709060-00003.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

34

Keniche, Assia, Samia Bellifa, Hafida Hassaine y Joseph Kajima Mulengi. "Development of new antibacterial agents". Medical Technologies Journal 1, n.º 2 (8 de junio de 2017): 31–32. http://dx.doi.org/10.26415/2572-004x-vol1iss2p31-32.

Texto completo

Resumen

Background: Antibiotics, as miraculous drugs, have been used extensively to confront fatal infection, even without prescriptions. However, the inappropriate and disproportionate use of antibiotics have led to the emergence of new drug-resistant bacteria1, which causes a high risk of serious diseases and dramatically aggravates the clinical complications in hospitals. Methods: By using the peptide coupling protocol, a simple straightforward synthesis of functionalized aziridines has been developed. By means of this synthetic strategy from readily available N-phtaloyl acide and 2-methylbenzosulfonate aziridine using DCC as coupling agent, new tosylates aziridines could be obtained. The coupling reactions occurred without a ring opening of the three membered ring. Results: This work describes new results of our ongoing research targeting new derivatives of biological interests. All the compounds were screened for their antibacterial activity; they all showed comparable moderate to good growth inhibitory activity with reference to tetracyclin and gentamicin. Conclusion: In conclusion, we reported the synthesis and a preliminary antibacterial evaluation of novel functionalized tosylaziridines. The synthetic strategy relies on the coupling reactions between tosylaziridines and amino acids. Moreover, and besides showing interesting antibacterial activities, the series of novel compounds can be further improved to serve as potential drug against nosocomial diseases.

Los estilos APA, Harvard, Vancouver, ISO, etc.

35

Mittapally, Sirisha, Ruheena Taranum y Sumaiya Parveen. "Metal ions as antibacterial agents". Journal of Drug Delivery and Therapeutics 8, n.º 6-s (15 de diciembre de 2018): 411–19. http://dx.doi.org/10.22270/jddt.v8i6-s.2063.

Texto completo

Resumen

Metals like mercury, arsenic, copper and silver have been used in various forms as antimicrobials for thousands of years. The use of metals in treatment was mentioned in Ebers Papyrus (1500BC); i.e, copper to decrease inflammation & iron to overcome anemia. Copper has been registered at the U.S. Environmental Protection Agency as the earliest solid antimicrobial material. Copper is used for the treatment of different E. coli, MRSA, Pseudomonas infections. Advantage of use of silver is it has low toxicity to human’s cells than bacteria.It is less susceptible to gram +ve bacteria than gram –bacteria due to its thicker cell wall. Zinc is found to be active against Streptococcus pneumonia, Campylobacter jejuni. Silver & zinc act against vibrio cholera & enterotoxic E. coli. The use of metals as antibacterial got reduce with discovery of antibiotics in twentieth century, immediately after that antibiotic resistance was seen due to transfer of antibiotic resistance genes by plasmids also known as Resistance Transfer Factors or R-factors. Metal complexes are used to show synergistic activity against bacteria’s like copper & chlorhexidine on dental plaque bacteria, silver nanoparticles & cephalexin against E. coli & S. aureus. Keywords: Metals, Oligodynamic effect, Copper, Silver

Los estilos APA, Harvard, Vancouver, ISO, etc.

36

Kong, Qidi y Yushe Yang. "Recent advances in antibacterial agents". Bioorganic & Medicinal Chemistry Letters 35 (marzo de 2021): 127799. http://dx.doi.org/10.1016/j.bmcl.2021.127799.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

37

Meneghetti, Fiorella y Daniela Barlocco. "Special Issue “Novel Antibacterial Agents”". Pharmaceuticals 14, n.º 4 (19 de abril de 2021): 382. http://dx.doi.org/10.3390/ph14040382.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

38

Wainwright, Nicholas J., Paul Collins y James Ferguson. "Photosensitivity Associated with Antibacterial Agents". Drug Safety 9, n.º 6 (diciembre de 1993): 437–40. http://dx.doi.org/10.2165/00002018-199309060-00006.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

39

Pasquale, T. R. y J. S. Tan. "Nonantimicrobial Effects of Antibacterial Agents". Clinical Infectious Diseases 40, n.º 1 (1 de enero de 2005): 127–35. http://dx.doi.org/10.1086/426545.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

40

Singal, Anjum y Gurvinder P. Thami. "Topical Antibacterial Agents in Dermatology". Journal of Dermatology 30, n.º 9 (septiembre de 2003): 644–48. http://dx.doi.org/10.1111/j.1346-8138.2003.tb00452.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

41

&NA;. "Nonantimicrobial Effects of Antibacterial Agents". Pediatric Infectious Disease Journal 24, n.º 4 (abril de 2005): 395. http://dx.doi.org/10.1097/01.inf.0000159186.41813.c1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

42

Joseph A., Witkowski y Charles Parish Lawrence. "Cutaneous Reactions to Antibacterial Agents". SKINmed: Dermatology for the Clinician 1, n.º 5 (septiembre de 2002): 33–44. http://dx.doi.org/10.1111/j.1540-9740.2002.01856.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

43

Couloigner, Evanne, Dominique Cartier y Roger Labie. "Synthesis of pyrazolidinone antibacterial agents". Bioorganic & Medicinal Chemistry Letters 9, n.º 15 (agosto de 1999): 2205–6. http://dx.doi.org/10.1016/s0960-894x(99)00352-2.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

44

Thorarensen, Atli, Gary E. Zurenko, Michael T. Sweeney, Keith R. Marotti y Timothy P. Boyle. "Enols as Potent Antibacterial Agents". Bioorganic & Medicinal Chemistry Letters 11, n.º 22 (noviembre de 2001): 2931–34. http://dx.doi.org/10.1016/s0960-894x(01)00587-x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

45

Chen, Luke F., Teena Chopra y Keith S. Kaye. "Pathogens Resistant to Antibacterial Agents". Medical Clinics of North America 95, n.º 4 (julio de 2011): 647–76. http://dx.doi.org/10.1016/j.mcna.2011.03.005.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

46

Kaye, Keith S. y Donald Kaye. "Antibacterial Therapy and Newer Agents". Medical Clinics of North America 95, n.º 4 (julio de 2011): xi—xii. http://dx.doi.org/10.1016/j.mcna.2011.05.001.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

47

Labro, Marie Thérèse. "Immunomodulatory Actions of Antibacterial Agents". Clinical Immunotherapeutics 6, n.º 6 (diciembre de 1996): 454–64. http://dx.doi.org/10.1007/bf03259367.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

48

Kern, Thomas J. "Antibacterial agents for ocular therapeutics". Veterinary Clinics of North America: Small Animal Practice 34, n.º 3 (mayo de 2004): 655–68. http://dx.doi.org/10.1016/j.cvsm.2003.12.010.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

49

Chiu, Loretta M. y Guy W. Amsden. "Intrapulmonary Pharmacokinetics of Antibacterial Agents". American Journal of Respiratory Medicine 1, n.º 3 (junio de 2002): 201–9. http://dx.doi.org/10.1007/bf03256610.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

50

Ballal, VasudevN y Jothi Varghese. "Antibacterial action of herbal agents". Saudi Endodontic Journal 5, n.º 1 (2015): 65. http://dx.doi.org/10.4103/1658-5984.149095.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!